An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

Please use this identifier to cite or link to this item: https://doi.org/10.1136/gut.52.5.671

Title:	An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
Authors:	Wagner, A. Kellow, J. Lee, O.Y. Chang, F.Y. Thongsawat, S. Mazlam, M.Z. Yuen, H. Gwee, K.A. Bak, Y.T. Jones, J.
Issue Date:	2003
Citation:	Wagner, A., Kellow, J., Lee, O.Y., Chang, F.Y., Thongsawat, S., Mazlam, M.Z., Yuen, H., Gwee, K.A., Bak, Y.T., Jones, J. (2003). An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 52 (5) : 671-676. ScholarBank@NUS Repository. https://doi.org/10.1136/gut.52.5.671
Source Title:	Gut
URI:	http://scholarbank.nus.edu.sg/handle/10635/117556
ISSN:	00175749
DOI:	10.1136/gut.52.5.671
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check